Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis

Allergol Int. 2024 Apr;73(2):332-334. doi: 10.1016/j.alit.2023.12.001. Epub 2023 Dec 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Biomarkers
  • Blepharitis* / chemically induced
  • Blepharitis* / diagnosis
  • Blepharitis* / drug therapy
  • Conjunctivitis* / chemically induced
  • Conjunctivitis* / diagnosis
  • Humans

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized
  • Biomarkers